Table 1.
Admission parameters and past medical history.
| N (out of) | % | |
|---|---|---|
| Clinical presentation | ||
| Gait disturbance/fall | 362 (618) | 58.6 |
| Headache | 286 (616) | 46.4 |
| Focal neurological deficit | 252 (619) | 40.7 |
| Cognitive deterioration | 246 (618) | 39.8 |
| Non-specific deterioration | 170 (617) | 27.6 |
| Speech disturbance | 155 (619) | 25.0 |
| Acute confusion | 115 (618) | 18.6 |
| Drowsiness/coma | 109 (618) | 17.6 |
| Vomiting/nausea | 60 (618) | 9.7 |
| Seizure | 44 (617) | 7.1 |
| Incontinence | 30 (615) | 4.9 |
| Past medical history | ||
| Hypertension | 367 (619) | 59.3 |
| Arrhythmia | 160 (619) | 25.8 |
| Ischemic heart disease | 148 (619) | 23.9 |
| Diabetes mellitus | 96 (619) | 15.5 |
| Renal insufficiency | 78 (619) | 12.6 |
| Dementia | 78 (619) | 12.6 |
| Cerebrovascular accident | 75 (619) | 12.1 |
| DVT/PE | 54 (619) | 8.7 |
| COPD | 29 (619) | 4.7 |
| Hepatic insufficiency | 22 (619) | 3.6 |
| Medication | ||
| Aspirin | 169 (618) | 27.3 |
| Clopidogrel | 26 (618) | 4.2 |
| Vitramin-K antagonist | 135 (619) | 21.8 |
| New OAK | 9 (618) | 1.5 |
Gait disturbance is the most prevalent symptom, and hypertension is the most common comorbidity. Anticoagulation and antiplatelet drugs were administered, respectively, by 31.5 and 22.3% of the patients.
COPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; PE, pulmonary embolism.